NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE148103 Query DataSets for GSE148103
Status Public on Sep 04, 2020
Title Chromatin profiling upon pharmacological LSD1 inhibition in MCC [CUT&RUN]
Organism Homo sapiens
Experiment type Genome binding/occupancy profiling by high throughput sequencing
Summary Merkel cell carcinoma (MCC) is a highly aggressive, neuroendocrine skin cancer that lacks actionable mutations, which could be utilized for targeted therapies. Epigenetic regulators governing cell identity may represent unexplored therapeutic entry points. Here, we targeted epigenetic regulators in a pharmacological screen and discovered that the lysine-specific histone demethylase 1A (LSD1/KDM1A) is required for MCC growth in vitro and in vivo. We show that LSD1 inhibition in MCC disrupts the LSD1-CoREST complex leading to displacement and degradation of HMG20B (BRAF35), a poorly characterized complex member that is essential for MCC proliferation. Inhibition of LSD1 causes derepression of transcriptional master regulators of the neuronal lineage, activates a gene expression signature resembling normal Merkel cells, and induces cell cycle arrest and cell death. Our study unveils the importance of LSD1 for proliferation and maintaining cell identity in MCC. There is growing evidence that cancer cells exploit cellular plasticity and dedifferentiation programs to evade destruction by the immune system. The combination of LSD1 inhibitors with checkpoint inhibitors may thus represent a promising treatment strategy for MCC patients.
 
Overall design CUT&RUN profiling of PeTa cell line upon pharmacological LSD1 inhibitor treatment.
Please note that each processed data file was generated from two replicates as indicated in the corresponding sample description field.
 
Contributor(s) Leiendecker L, Jung PS, Krecioch I, Neumann T, Schleiffer A, Mechtler K, Wiesner T, Obenauf AC
Citation(s) 33026191
Submission date Apr 05, 2020
Last update date Dec 04, 2020
Contact name Anna Obenauf
Organization name IMP - Research Institute of Molecular Pathology
Lab Anna Obenauf
Street address Campus-Vienna-Biocenter 1
City Vienna
State/province Vienna
ZIP/Postal code 1030
Country Austria
 
Platforms (1)
GPL11154 Illumina HiSeq 2000 (Homo sapiens)
Samples (16)
GSM4454154 10_GSK_100nM_d6_H3K4me1
GSM4454155 1.1_DMSO_d6_pig
GSM4454156 1.2_DMSO_d6_pig
This SubSeries is part of SuperSeries:
GSE147817 Pharmacological LSD1 inhibition in MCC
Relations
BioProject PRJNA623225
SRA SRP255313

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE148103_DMSO_d6_H3K27ac.bam.normalized.bw 89.0 Mb (ftp)(http) BW
GSE148103_DMSO_d6_H3K27me3.bam.normalized.bw 56.0 Mb (ftp)(http) BW
GSE148103_DMSO_d6_H3K4me1.bam.normalized.bw 59.1 Mb (ftp)(http) BW
GSE148103_GSK_d6_H3K27ac.bam.normalized.bw 86.8 Mb (ftp)(http) BW
GSE148103_GSK_d6_H3K27me3.bam.normalized.bw 110.1 Mb (ftp)(http) BW
GSE148103_GSK_d6_H3K4me1.bam.normalized.bw 84.1 Mb (ftp)(http) BW
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap